#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	16	278	ANT_2____Ia	750	210	100.0	ANT_2____Ia.l6.c4.ctg.1	661	22.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ANT(2'')-Ia;Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	866	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1199	39.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	348	350	ACG	51;52;53	A;C;G	51;52;53	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	T879G	SNP	879	879	T	34	34	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	G880A	SNP	880	880	G	35	35	A	3	A	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	A888G	SNP	888	888	A	43	43	G	6	G	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	C897G	SNP	897	897	C	52	52	G	11	G	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	T898C	SNP	898	898	T	53	53	C	13	C	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	G906T	SNP	906	906	G	61	61	T	20	T	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	G908A	SNP	908	908	G	63	63	A	22	A	22	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	A918T	SNP	918	918	A	73	73	T	25	T	25	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	A943G	SNP	943	943	A	98	98	G	67	G,C	66,1	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	424	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	192	24.5	0	.	n	.	0	G991T	SNP	991	991	G	146	146	T	53	T	53	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	1	SNP	p	R234F	1	.	.	700	702	TTC	832	834	TTC	151;150;156	T;T;C	150;150;155	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1132	1134	CGT	106;107;108	C;G;T	105;107;108	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	0	HET	.	.	.	C261T	.	261	261	C	393	393	C	103	C,T	59,43	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	0	HET	.	.	.	T999C	.	999	999	T	1131	1131	T	100	T,C	58,42	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	0	HET	.	.	.	C144T	.	144	144	C	276	276	C	68	C,T	42,26	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	0	HET	.	.	.	T180C	.	180	180	T	312	312	T	57	T,C	34,20	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	1210	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1342	103.6	0	HET	.	.	.	T90C	.	90	90	T	222	222	T	71	T,C	52,19	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2842	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l6.c17.ctg.4	178	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	778	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1839	22.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1576	1578	AAA	7;7;7	A;A;A	7;7;7	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1342	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1724	41.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1253	1255	GAA	61;61;60	G;A;A	61;61;60	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	250	H_NS	414	414	99.03	H_NS.l15.c17.ctg.1	499	23.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	14	14	G	156	G	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	15	15	T	160	T	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1136G	SNP	1136	1136	A	109	109	G	222	G	220	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1138C	SNP	1138	1138	T	111	111	C	217	C	217	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1142C	SNP	1142	1142	T	115	115	C	207	C,T	206,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	C1170T	SNP	1170	1170	C	143	143	T	216	T	215	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1220C	SNP	1220	1220	T	193	193	C	208	C	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1245C	SNP	1245	1245	T	218	218	C	160	C	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1253A	SNP	1253	1253	G	226	226	A	164	A	163	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1256A	SNP	1256	1256	G	229	229	A	167	A	167	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	C1258A	SNP	1258	1258	C	231	231	A	166	A	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1266T	SNP	1266	1266	G	239	239	T	178	T	177	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1267C	SNP	1267	1267	T	240	240	C	179	C	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1275C	SNP	1275	1275	T	248	248	C	165	C	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1276A	SNP	1276	1276	G	249	249	A	165	A	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1281G	SNP	1281	1281	A	254	254	G	166	G	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1283C	SNP	1283	1283	T	256	256	C	166	C	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1288T	SNP	1288	1288	G	261	261	T	173	T	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1296G	SNP	1296	1296	A	269	269	G	203	G	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1299G	SNP	1299	1299	T	272	272	G	213	G	213	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1300T	SNP	1300	1300	A	273	273	T	212	T	210	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	C1356T	SNP	1356	1356	C	329	329	T	202	T	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1358G	SNP	1358	1358	A	331	331	G	192	G	192	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1368C	SNP	1368	1368	T	341	341	C	154	C	154	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1370A	SNP	1370	1370	G	343	343	A	138	A	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	C1406.	DEL	1406	1406	C	378	378	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	.1409C	INS	1409	1409	T	382	382	C	78	C	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	C1431A	SNP	1431	1431	C	404	404	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	C1432A	SNP	1432	1432	C	405	405	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1441G	SNP	1441	1441	A	414	414	G	6	G	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	T1464C	SNP	1464	1464	T	437	437	C	16	C	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	G1473T	SNP	1473	1473	G	446	446	T	77	T	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1475G	SNP	1475	1475	A	448	448	G	87	G	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	.	n	.	0	A1548T	SNP	1548	1548	A	521	521	T	92	T	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	1	SNP	n	C1194G	0	.	.	1194	1194	C	167	167	C	224	C	224	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	688	3634	Pasteurella_multocida_16S	1551	524	91.81	Pasteurella_multocida_16S.l15.c30.ctg.3	561	172.1	0	HET	.	.	.	T1040C	.	1040	1040	T	13	13	T	141	T,C	47,47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1070	PmrB_1	1092	1092	99.27	PmrB_1.l6.c4.ctg.1	1579	36.5	0	.	p	.	0	H2R	NONSYN	4	6	CAT	290	292	CGT	28;29;29	C;G;T	28;29;29	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1070	PmrB_1	1092	1092	99.27	PmrB_1.l6.c4.ctg.1	1579	36.5	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1133	1135	GGC	38;39;37	G;G;C	38;39;37	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1606	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2059	41.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	173	175	AGC	11;11;11	A;G;C	11;11;10	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1606	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2059	41.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	575	577	CTA	34;35;35	C;T;A	34;35;35	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1606	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2059	41.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1094	1096	CAA	58;58;59	C;A;A	58;58;59	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1606	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2059	41.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1193	1195	GGT	79;82;80	G;G;T	79;82;80	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1606	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2059	41.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1763	1765	GTT	34;31;32	G;T;T	34;31;32	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	692	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1603	23.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	556	558	GAA	25;24;24	G;A;A	24;23;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	692	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1603	23.2	0	.	p	.	0	M185T	NONSYN	553	555	ATG	736	738	ACC	16;16;16	A;C;C	16;16;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	692	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1603	23.2	0	.	p	.	0	S225T	NONSYN	673	675	TCC	856	858	ACT	22;25;25	A;C;T	21;25;25	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	692	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1603	23.2	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1246	1248	ATC	20;21;21	A;T;C	19;20;21	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	790	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1431	29.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_002134_NP_052897.3_13536_14546	aada1.manually_added_NC_002134_NP_052897.3_13536_14546	1	0	528	262	aad-	1011	214	98.6	aad-.l6.c4.ctg.1	661	21.3	0	.	p	.	0	G32del	DEL	94	94	G	328	328	T	22	T	22	.	Original ref seq: NC_002134.1 Shigella flexneri 2b plasmid R100 DNA, complete sequence
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2326	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3518	35.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	479	481	ATC	33;31;29	A;T;C	33;31;29	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2326	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3518	35.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2192	2194	AAG	26;25;26	A;A;G	26;25;26	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	658	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1131	31.4	1	SNP	p	R45C	0	.	.	133	135	CGC	413	415	CGC	42;41;40	C;G;C	42;40;40	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	596	acrS	663	663	98.79	acrS.l15.c30.ctg.1	869	35.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	174	176	TTC	35;33;34	T;T;C	34;33;34	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	596	acrS	663	663	98.79	acrS.l15.c30.ctg.1	869	35.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	438	440	GGG	32;30;31	G;G;G	32;30;31	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	674	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1158	31.3	0	.	p	.	0	V136L	NONSYN	406	408	GTT	607	609	CTT	54;55;54	C;T;T	54;55;54	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2682	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3141	45.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2113	2115	GCA	52;51;51	G;C;A	52;51;50	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2682	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3141	45.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2374	2376	ACC	49;50;51	A;C;C	48;50;51	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2682	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3141	45.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2683	2685	GCC	39;41;39	G;C;C	38;40;39	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	295	297	GCT	6;7;7	G;C;T	6;7;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	415	417	GAG	8;7;7	G;A;G	8;7;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	451	453	TGC	16;16;16	T;G;C	16;16;16	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	634	636	GTT	28;31;31	G;T;T	28;30;31	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	784	786	CAC	28;26;25	C;A;C	28;26;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1069	1071	ATG	40;41;41	A;T;G	39;39;40	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1248	arnA_1	1983	1983	98.29	arnA_1.l6.c17.ctg.1	2351	28.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2065	2067	CGC	13;13;11	C;G;C	13;13;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	498	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1246	21.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	877	879	ACC	22;21;19	A;C;C	22;21;19	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	498	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1246	21.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	889	891	TCG	19;20;20	T;C;G	19;20;20	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	490	baeR	723	723	97.79	baeR.l15.c17.ctg.1	1159	22.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1514	27.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1225	1227	AAA	7;7;8	A;A;A	6;7;8	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1514	27.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1237	1239	GAG	8;9;9	G;A;G	7;9;8	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1514	27.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1243	1245	CAC	9;8;10	C;A;C	8;8;10	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	816	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1514	27.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1297	1299	GAG	21;22;21	G;A;G	21;22;21	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1268	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	1903	35.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	866	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1163	40.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	600	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1313	24.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA5.manually_added_X12868_CAA31356.1_1306_1779	dfrA5.manually_added_X12868_CAA31356.1_1306_1779	1	0	27	370	dfrA5	474	474	100.0	dfrA5.l15.c4.ctg.1	847	23.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: X12868.1 Plasmid pLMO20 dhfrV gene for trimethoprim resistance
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1006	emrA	1173	1173	98.38	emrA.l6.c30.ctg.1	1645	32.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	883	885	GTC	57;57;55	G;T;C	57;54;54	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1352	emrB	1539	1539	99.81	emrB.l6.c17.ctg.1	2016	36.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1084	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1682	34.6	0	.	p	.	0	G209S	NONSYN	625	627	GGC	816	818	AGC	29;29;28	A;G;C	29;29;27	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	24	emrE_1	333	93	96.77	emrE_1.l15.c4.ctg.1	123	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	740	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1298	28.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	724	726	AGG	21;21;22	A;G;G	21;21;22	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	740	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1298	28.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1114	1116	GAC	12;12;12	G;A;C	12;12;12	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	638	emrR	531	531	100.0	emrR.l15.c30.ctg.1	988	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1134	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2073	29.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	458	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1047	23.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	383	385	CTG	28;28;27	C;T;G	28;28;27	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	196	198	AAA	19;19;18	A;A;A	19;19;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	931	933	CAT	18;17;17	C;A;T	18;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	985	987	CAT	21;21;20	C;A;T	21;21;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1003	1005	AGA	24;24;23	A;G;A	24;24;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1018	1020	AAT	19;19;19	A;A;T	19;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1165	1167	TCC	10;11;13	T;C;C	10;11;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1330	1332	ATT	25;26;26	A;T;T	25;26;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1351	1353	GAT	21;21;23	G;A;T	21;21;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1465	1467	GTT	37;37;37	G;T;T	37;37;37	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	2490	97.91	evgS.l15.c30.ctg.1	2652	31.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1750	1752	CAC	30;28;27	C;A;C	30;28;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	196	198	ATA	14;14;14	A;T;A	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	208	210	GTA	8;8;8	G;T;A	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	361	363	ACG	27;30;30	A;C;G	27;30;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	424	426	GAA	34;34;34	G;A;A	34;34;34	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	463	465	GCT	37;36;38	G;C;T	37;36;38	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	481	483	GAT	31;30;30	G;A;T	31;30;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	568	570	TCA	18;19;18	T;C;A	18;19;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	697	699	CAG	16;17;17	C;A;G	16;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	835	837	GTT	20;20;20	G;T;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	991	993	GAT	6;6;6	G;A;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2064	evgS	3594	1092	96.98	evgS.l15.c30.ctg.2	1176	22.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1159	1161	AAT	4;4;4	A;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	766	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1284	32.1	1	SNP	p	P64H	0	.	.	190	192	CCA	434	436	CCA	59;61;58	C;C;A	59;61;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	766	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1284	32.1	1	SNP	p	P64S	0	.	.	190	192	CCA	434	436	CCA	59;61;58	C;C;A	59;61;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	766	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1284	32.1	1	SNP	p	P64R	0	.	.	190	192	CCA	434	436	CCA	59;61;58	C;C;A	59;61;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	766	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1284	32.1	1	SNP	p	P64A	0	.	.	190	192	CCA	434	436	CCA	59;61;58	C;C;A	59;61;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	766	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1284	32.1	1	SNP	p	P64L	0	.	.	190	192	CCA	434	436	CCA	59;61;58	C;C;A	59;61;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	470	gadE	528	528	100.0	gadE.l15.c30.ctg.1	940	26.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	231	96.1	gadW.l15.c4.ctg.1	332	14.5	0	.	p	.	0	S234A	NONSYN	700	702	TCG	202	204	GCG	11;13;13	G;C;G	11;13;13	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	E54D	NONSYN	160	162	GAA	20	22	GAT	5;6;6	G;A;T	5;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	I88M	NONSYN	262	264	ATA	122	124	ATG	3;3;3	A;T;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	125	127	CCG	3;3;3	C;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	D100E	NONSYN	298	300	GAC	158	160	GAA	4;4;3	G;A;A	4;4;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	P101S	NONSYN	301	303	CCC	161	163	TCC	3;3;3	T;C;C	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	R102G	NONSYN	304	306	CGG	164	166	GGG	3;3;3	G;G;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l15.c4.ctg.2	319	6.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	188	190	AAT	5;5;5	A;A;T	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1139	26.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	370	372	TTA	36;35;35	T;T;A	36;35;35	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1139	26.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	448	450	ATT	23;22;20	A;T;T	23;22;20	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1139	26.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	949	951	GGA	11;12;12	G;G;A	11;12;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	560	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1139	26.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	955	957	CCG	15;15;15	C;C;G	14;14;15	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2254	2256	GAA	28;28;30	G;A;A,C	28;28;29,1	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	S83W	0	.	.	247	249	TCG	469	471	TCG	43;40;38	T;C;G	41;38;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	S83I	0	.	.	247	249	TCG	469	471	TCG	43;40;38	T;C;G	41;38;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	S83L	0	.	.	247	249	TCG	469	471	TCG	43;40;38	T;C;G	41;38;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	D87N	0	.	.	259	261	GAC	481	483	GAC	32;32;32	G;A;C	30;29;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	D87H	0	.	.	259	261	GAC	481	483	GAC	32;32;32	G;A;C	30;29;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	D87G	0	.	.	259	261	GAC	481	483	GAC	32;32;32	G;A;C	30;29;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	481	483	GAC	32;32;32	G;A;C	30;29;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2366	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3101	41.0	1	SNP	p	D87V	0	.	.	259	261	GAC	481	483	GAC	32;32;32	G;A;C	30;29;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136G	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136E	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136I	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136L	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136H	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136C	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2250	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2923	41.3	1	SNP	p	R136S	0	.	.	406	408	CGC	685	687	CGC	37;39;39	C;G;C	36;39;39	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	368	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	943	20.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	359	361	CCG	28;27;24	C;C;G	27;25;24	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	368	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	943	20.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	512	514	GCC	27;27;26	G;C;C	27;27;26	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	920	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1278	38.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	171	173	TCA	31;31;31	T;C;A	31;31;31	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	274	marA	384	384	99.74	marA.l15.c4.ctg.1	907	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	523	525	AGC	19;19;18	A;G;C	19;19;18	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	625	627	CAT	5;4;4	C;A;T	5;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	V45E	0	.	.	133	135	GTG	349	351	GTG	23;22;23	G;T;G	22;22;23	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	I49S	0	.	.	145	147	ATC	361	363	ATC	27;27;27	A;T;C	27;27;27	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	A70T	0	.	.	208	210	GCA	424	426	GCA	12;12;12	G;C;A	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	R73S	0	.	.	217	219	CGT	433	435	CGT	11;10;10	C;G;T	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	R73C	0	.	.	217	219	CGT	433	435	CGT	11;10;10	C;G;T	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	R77L	0	.	.	229	231	CGC	445	447	CGC	10;11;11	C;G;C	10;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	R77C	0	.	.	229	231	CGC	445	447	CGC	10;11;11	C;G;C	10;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	L78M	0	.	.	232	234	CTG	448	450	CTG	11;11;11	C;T;G	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	R94S	0	.	.	280	282	CGC	496	498	CGC	10;9;9	C;G;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	R94H	0	.	.	280	282	CGC	496	498	CGC	10;9;9	C;G;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	138	marR	435	434	97.7	marR.l15.c30.ctg.1	650	10.9	1	SNP	p	V96E	0	.	.	286	288	GTA	502	504	GTA	8;10;14	G;T;A	8;10;14	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	21	23	TTC	1;1;1	T;T;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	108	110	ATC	11;11;11	A;T;C	11;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	126	128	GCC	1;1;1	G;C;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	129	131	GTG	1;1;1	G;T;G	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	156	158	GAT	4;4;4	G;A;T	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	177	179	ACC	5;6;6	A;C;C	5;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	204	206	TTA	7;7;8	T;T;A	7;7;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	345	347	CAG	34;36;36	C;A;G	33;35;36	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	384	386	GCC	24;24;25	G;C;C	24;24;25	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	489	491	GCG	18;19;20	G;C;G	18;18;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	A227_L228del	DEL	679	679	G	680	680	G	10	G	8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	687	689	GTT	12;12;12	G;T;T	11;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	562	mdfA	1233	1233	96.51	mdfA.l6.c17.ctg.1	1418	20.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	849	849	C	18	C	17	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	566	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1413	19.9	0	.	p	.	0	V12trunc	TRUNC	34	34	G	45	45	G	33	G	32	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	566	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1413	19.9	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	102	104	CAG	10;9;9	C;A;G	10;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	566	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1413	19.9	0	.	p	.	0	T83I	NONSYN	247	249	ACC	252	254	ATC	15;14;13	A;T;C	14;13;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	566	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1413	19.9	0	.	p	.	0	I99M	NONSYN	295	297	ATA	300	302	ATG	8;10;11	A;T;G	8;10;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	566	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1413	19.9	0	.	p	.	0	A130T	NONSYN	388	390	GCC	393	395	ACC	12;12;11	A;C;C	12;12;11	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1947	1949	ACC	38;35;34	A;C;C	38;35;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2340	2342	CAA	26;24;22	C;A;A	26;24;21	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2508	2510	ATT	20;20;20	A;T;T	20;20;20	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2592	2594	GTT	22;23;22	G;T;T	22;23;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2700	2702	GAG	18;17;17	G;A;G	18;17;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2928	2930	ATG	20;21;21	A;T;G	20;21;21	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2320	mdtB	3123	3123	98.91	mdtB.l15.c4.ctg.1	3466	36.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3063	3065	GAT	23;22;23	G;A;T	23;22;21	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1976	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3304	31.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	331	333	ATG	19;19;19	A;T;G	18;19;19	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1976	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3304	31.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	817	819	ATC	49;49;50	A;T;C	48;49;50	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1976	mdtC	3078	3078	98.7	mdtC.l15.c17.ctg.1	3304	31.8	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3133	3135	CAC	1;1;1	C;A;C	1;1;1	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	890	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1853	25.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	223	225	GAA	15;15;15	G;A;A	15;15;15	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	890	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1853	25.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	892	894	GCG	25;24;24	G;C;G	25;24;24	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	890	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1853	25.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1234	1236	ATC	37;36;35	A;T;C	36;35;34	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	890	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1853	25.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1537	1539	TTT	31;32;31	T;T;T	31;31;30	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1210	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1591	40.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2994	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3573	45.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1095	1097	ACC	36;36;35	A;C;C	36;34;35	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2994	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3573	45.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2337	2339	GAC	58;58;59	G;A;C	56;57;57	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	902	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1502	26.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	623	625	ATC	28;29;32	A;T;C	28;29;32	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	902	mdtG	1227	174	99.43	mdtG.l15.c4.ctg.2	376	15.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	5	7	GGA	2;2;4	G;G;A	2;2;4	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	754	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1637	24.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	633	635	TGT	28;29;29	T;G;T	28;29;29	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	754	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1637	24.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1203	1205	TTG	38;36;36	T;T;G	36;36;36	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	754	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1637	24.7	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1308	1310	CAG	6;6;7	C;A;G	6;6;7	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	754	mdtH	1209	1209	98.1	mdtH.l6.c30.ctg.1	1637	24.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1413	1415	ACG	11;10;10	A;C;G	10;10;10	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1186	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1646	38.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	755	757	TCC	27;26;26	T;C;C	26;26;26	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	724	mdtN	1032	1032	98.16	mdtN.l15.c4.ctg.1	1479	26.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	540	542	ATT	23;23;23	A;T;T	23;23;22	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	122	124	ATG	26;27;28	A;T;G	26;27;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	188	190	ATC	22;22;24	A;T,C;C	22;21,1;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	437	439	CGC	64;64;59	C;G;C	64;64;59	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	803	805	AGC	44;43;42	A;G;C	44;42;42	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1004	1006	GTG	32;32;31	G;T;G	32;27;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1067	1069	AAC	13;14;15	A;A;C	13;14;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1112	1114	GTC	31;31;32	G;T;C	31;31;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1142	1144	ATA	39;39;38	A;T;A	39;39;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1250	1252	TCT	23;25;26	T;C;T	23;25;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1637	1639	GCG	38;38;39	G;C;G	38;37;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1642	mdtO	2052	2052	98.15	mdtO.l15.c4.ctg.1	2408	36.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1850	1852	ATC	26;25;26	A;T;C	26;25;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	598	600	GCG	35;34;34	G;C;G	35;33;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	772	774	ACC	24;25;26	A;C;C	24;24;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	844	846	CGC	40;37;35	C;G;C	40;37;35	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	961	963	GCT	25;24;25	G;C;T	23;23;24	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1045	1047	AAA	13;13;13	A;A;A	13;13;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1063	1065	CGA	11;11;11	C;G;A	11;11;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1228	1230	GCC	25;25;24	G;C;C	24;25;24	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1240	1242	GAT	22;23;23	G;A;T	22;23;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1070	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1715	32.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1657	1659	GCT	16;14;12	G;C;T	16;14;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2348	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3888	32.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1545	1547	AAG	27;26;26	A;A;G	27;26;26	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2348	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3888	32.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2622	2624	CTG	24;24;23	C;T;G	24;23;23	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	186	mgrB	144	144	100.0	mgrB.l15.c17.ctg.1	329	22.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1756	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2237	42.2	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1090	1092	AAC	39;39;41	A;A;C	39;39;41	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1756	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2237	42.2	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1636	1638	ATA	45;46;46	A;T;A	45;46;46	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1324	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1704	41.8	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1286	1288	GTG	53;55;57	G;T;G	53;55;57	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1324	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1704	41.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1364	1366	GAT	54;53;50	G;A;T	54;53;50	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	1324	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1704	41.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1367	1369	CTG	51;51;52	C;T;G	51;51;52	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	311	313	TGT	29;27;27	T;G;T	29;27;27	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	581	583	ACC	31;30;31	A;C;C	30;30;31	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	0	.	p	.	0	G187D	NONSYN	559	561	GGC	791	793	GAC	16;16;19	G;A;C	16;16;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	1	SNP	p	R15C	0	.	.	43	45	CGC	275	277	CGC	42;41;41	C;G;C	42;41;41	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	1	SNP	p	S33R	0	.	.	97	99	AGC	329	331	AGC	31;31;30	A;G;C	31;31;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	1	SNP	p	G131D	0	.	.	391	393	GGC	623	625	GGC	37;36;35	G;G;C	36;36;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	1	SNP	p	R203C	0	.	.	607	609	CGT	839	841	CGT	33;33;33	C;G;T	33;33;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	470	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1159	21.5	1	SNP	p	R203L	0	.	.	607	609	CGT	839	841	CGT	33;33;33	C;G;T	33;33;33	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1272	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1523	44.9	1	SNP	p	G141D	0	.	.	421	423	GGT	650	652	GGT	60;59;58	G;G;T	60;58;57	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1272	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1523	44.9	1	SNP	p	G141E	0	.	.	421	423	GGT	650	652	GGT	60;59;58	G;G;T	60;58;57	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1272	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1523	44.9	1	SNP	p	R154A	0	.	.	460	462	CGT	689	691	CGT	67;67;66	C;G;T	67;67;65	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	1272	ompF	1089	1089	100.0	ompF.l15.c30.ctg.1	1523	44.9	1	SNP	p	R154D	0	.	.	460	462	CGT	689	691	CGT	67;67;66	C;G;T	67;67;65	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2238	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2709	44.5	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1844	1846	TCG	56;56;59	T;C;G	54;55;56	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2238	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2709	44.5	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2459	2461	AAC	33;34;35	A;A;C	33;34;35	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2238	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2709	44.5	1	SNP	p	A85T	0	.	.	253	255	GCG	473	475	GCG	51;52;52	G;C;G	49;51;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2238	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2709	44.5	1	SNP	p	D111H	0	.	.	331	333	GAT	551	553	GAT	32;32;33	G;A;T	32;32;32	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2238	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2709	44.5	1	SNP	p	S129P	0	.	.	385	387	TCC	605	607	TCC	56;56;56	T;C;C	56;56;56	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	1348	parE_1	1893	1893	97.57	parE_1.l6.c30.ctg.1	2393	30.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1665	1667	GAT	66;66;63	G;A;T	66;66;63	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1228	patA	1380	1380	99.86	patA.l15.c17.ctg.1	1843	35.8	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1297	1299	GAT	45;46;47	G;A;T	45;45;47	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	V146F	0	.	.	436	438	GTT	685	687	GTT	53;52;52	G;T;T	53;52;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1786	1788	CAG	63;64;65	C;A;G	63;64;65	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1786	1788	CAG	63;64;65	C;A;G	63;64;65	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1825	1827	CAC	45;43;43	C,A;A;C	43,1;43;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1834	1836	CGT	36;35;36	C;G;T	36;35;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1834	1836	CGT	36;35;36	C;G;T	36;35;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1840	1842	TCC	38;38;37	T;C;C	38;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1846	1848	CTC	37;34;37	C;T;C	37;34;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1936	1938	ACC	50;51;51	A;C;C	50;51;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1939	1941	CCT	53;52;53	C;C;T	53;52;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4504	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4522	53.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2308	2310	CGT	85;86;79	C;G;T	85;86;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.1	516	363.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	204	A	203	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.1	516	363.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	204	A	203	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.1	516	363.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	204	A	203	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	.	n	.	0	A226G	SNP	226	226	A	372	372	G	405	G	404	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	.	n	.	0	C719T	SNP	719	719	C	865	865	T	272	T,C	164,107	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	1	SNP	n	A794G	0	.	.	794	794	A	940	940	A	251	A	246	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	1	SNP	n	A794T	0	.	.	794	794	A	940	940	A	251	A	246	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	1	SNP	n	G926T	0	.	.	926	926	G	1072	1072	G	265	G	264	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	1	SNP	n	G926C	0	.	.	926	926	G	1072	1072	G	265	G	264	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	1	SNP	n	G926A	0	.	.	926	926	G	1072	1072	G	265	G	264	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	A79G	.	79	79	A	225	225	A	303	A,G	238,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	T273A	.	273	273	T	419	419	T	326	T,A	248,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	C183T	.	183	183	C	329	329	C	331	C,T	271,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	T90C	.	90	90	T	236	236	T	285	T,C	224,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	A250T	.	250	250	A	396	396	A	347	A,T	281,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	G474A	.	474	474	G	620	620	G	339	G,A	297,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	1001	99.8	rrsB+.l15.c30.ctg.2	1147	286.8	0	HET	.	.	.	A253T	.	253	253	A	399	399	A	345	A,T	281,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	60.8	0	.	n	.	0	G1002A	SNP	1002	1002	G	53	53	A	117	A	117	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	60.8	0	.	n	.	0	G1006C	SNP	1006	1006	G	57	57	C	121	C	121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	60.8	0	.	n	.	0	T1010C	SNP	1010	1010	T	61	61	C	125	C	125	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	60.8	0	.	n	.	0	A1019.	DEL	1019	1019	A	69	69	G	121	G	121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	60.8	0	.	n	.	0	.1023G	INS	1023	1023	T	74	74	G	119	G	119	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.4	142	60.8	0	.	n	.	0	C1038T	SNP	1038	1038	C	89	89	T	103	T	103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10770	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.6	143	62.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	568	soxR	465	465	100.0	soxR.l15.c4.ctg.1	919	33.2	1	SNP	p	R20H	0	.	.	58	60	CGC	238	240	CGC	50;53;56	C;G;C	49;53;55	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	568	soxR	465	465	100.0	soxR.l15.c4.ctg.1	919	33.2	1	SNP	p	G121D	0	.	.	361	363	GGT	541	543	GGT	62;64;63	G;G;T	62;64;63	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	16	442	soxS_1	324	235	99.57	soxS_1.l15.c30.ctg.1	460	32.3	1	SNP	p	A12S	0	.	.	34	36	GCA	207	209	GCA	62;63;62	G;C;A	62;63;62	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul1.manually_added_NC_002134_NP_052895.3_12192_13058	sul1.manually_added_NC_002134_NP_052895.3_12192_13058	1	0	27	454	sul1	867	867	100.0	sul1.l15.c17.ctg.1	1277	18.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_002134.1 Shigella flexneri 2b plasmid R100 DNA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1554	tolC	1488	1488	98.66	tolC.l15.c30.ctg.1	1963	42.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
